September 7, 2016: FemPulse Receives Institutional Review Board Approval
The Company announced today approval of the First-in-Human (FIH) clinical study of its novel, wearable neuromodulation platform for treating overactive bladder (OAB) in females. The Western IRB (WIRB) approved participation of up to 15 subjects in a study assessing fit, patient placement and safety of the FemPulse device, as well as potential for improvement in […]
